Spider venom peptides for gene therapy of Chlamydia infection

21Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Spider venoms are vast natural pharmacopoeias selected by evolution. The venom of the ant spider Lachesana tarabaevi contains a wide variety of antimicrobial peptides. We tested six of them (latarcins 1, 2a, 3a, 4b, 5, and cytoinsectotoxin 1a) for their ability to suppress Chlamydia trachomatis infection. HEK293 cells were transfected with plasmid vectors harboring the genes of the selected peptides. Controlled expression of the transgenes led to a significant decrease of C. trachomatis viability inside the infected cells. Copyright © 2011, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Lazarev, V. N., Polina, N. F., Shkarupeta, M. M., Kostrjukova, E. S., Vassilevski, A. A., Kozlov, S. A., … Govorun, V. M. (2011). Spider venom peptides for gene therapy of Chlamydia infection. Antimicrobial Agents and Chemotherapy, 55(11), 5367–5369. https://doi.org/10.1128/AAC.00449-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free